Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Predictors of Response Following CBT, IPT and Pharmacotherapy in Major Depression
NCT00744406Phase 2Completed
- Sponsor
- Center for Addiction and Mental Health
- Start
- Jul 2003
- Primary completion
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sertraline, paroxetine, venlafaxine in major depressive disorder (MDD), sponsored by Center for Addiction and Mental Health. Started Jul 2003; status: completed.
02
Drugs
sertralineparoxetinevenlafaxine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00744406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00744406.